DIA: Driving Insights to Action
Science:Life Sciences
The 21st Century Cures Act provides significant funding for scientific and medical research to promote innovation that speeds development of treatments for cancer and similar devastating diseases. Many such innovations, like using real-world evidence and patient-centered drug development, themselves require innovation in how data is collected and analyzed as scientific and regulatory evidence. In this exclusive podcast, Deputy Director for the Duke Margolis Center for Health Policy Dr. Gregory Daniel shares his expert perspective on the role that statisticians will play in advancing these initiatives. A Senior Advisor to the Reagan-Udall Foundation for the FDA, Dr. Daniel will also be a featured speaker at DIA’s Annual Statistics Forum. “What FDA really needs is to engage with statisticians within FDA but also outside of FDA, to better understand these statistical techniques, establish best practices for them, and how to ensure that their results are valid and reliable,” he explains. Register to attend DIA’s Annual Statistics Forum!
Regulatory & Ethical Considerations in a Pediatric Trial
Patient-Focused Drug Development: What Must We Still Do?
Interchangeable Biosimilars: A Global Perspective
Game Technology Opens New Path to Clinical Endpoints
Challenges and Opportunities for South Africa’s New Regulatory System
Clinical, Data, and Quantitative Science Now Converging
Realizing the Full Potential of CRISPR: Is the Hype Getting in the Way of Progress?
Tackling Ethical Questions in Clinical Research and Drug Development
WHO 2030 Framework for Efficient, Effective Regulation
AI: Opportunity for More Informed Drug Development Decisions
Clinical Training Critical in China’s Cancer Fight
Changing Research in China: From Generics to Innovators
Running Away from Addiction Has Caught Up with US
Has the Time for Big/Real World Data Finally Arrived?
Will AI Make Workers More (or Less) Valuable?
PvPI: Technology Meets Opportunity to Improve Safety
New EU CTR: One Application, One Portal, One Decision
US Generic Drug Policy: Less Cost, Same Impact
Multiple Pathways Complicate Opioid Pain Management
Breakthrough for Patients & Regulatory Science
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Ground Truths